Skip to main content

Table 2 Baseline demographic and clinical variables of the Traumeel S® and placebo treatment groups.

From: Traumeel S® for pain relief following hallux valgus surgery: a randomized controlled trial

  Traumeel S®
(n = 39)
Placebo
(n = 40)
Clinical Center:   
   SZMC* 33 34
   MMC** 6 6
Age (y)   
   Mean (SD) 48.1 (16.7) 45.2 (18.7)
   < 50 17 19
   ≥ 50 22 21
Sex (%)   
   M 8 (20.5) 8 (20.0)
   F 31 (79.5) 32 (80.0)
Ethnicity/Origin (%)   
   Europe/America 12 (30.8) 9 (22.5)
   Asia/Africa 21 (53.9) 25 (62.5)
   Israeli Arab 2 (5.1) 0
   Mixed 2 (5.1) 2 (5.0)
   Other 2 (5.1) 4 (10.0)
BMI   
   Mean (SD) 24.7 (4.1) 24.3 (4.0)
   < 24 20 23
   ≥ 24 18 16
Pain before surgery   
   Mean (SD) 5.4 (2.8) 5.7 (2.6)
   < 6 19 18
   ≥ 6 20 21
Laterality (%)   
   Right 21 (53.9) 14 (35.9)
   Left 16 (41.0) 24 (61.5)
   Bilateral# 2 (5.1) 1 (2.6)
Type of surgery (%)   
   Chevron - only 9 (23.0) 10†† (26.3)
   Additional 17 (43.5) 18 (47.3)
   osteotomy   
   Triple or 13 (33.3) 10 (26.3)
   proximal   
   osteotomy   
  1. * SZMC -- Shaare Zedek Medical Center
  2. **MMC -- Meir Medical Center
  3. #3 patients had a bilateral hallux valgus but underwent surgery on only one foot.
  4. - includes 1 patient with missing data.
  5. ††-includes 2 patients with missing data.